BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20215904)

  • 1. Pathways to further boost treatment rates and clinical outcomes in hospitalized stroke patients.
    Ovbiagele B
    Crit Pathw Cardiol; 2010 Mar; 9(1):8-13. PubMed ID: 20215904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways and tools of Stroke PROTECT: a hospital-based recurrent stroke prevention program.
    Ovbiagele B
    Crit Pathw Cardiol; 2009 Dec; 8(4):151-5. PubMed ID: 19952549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.
    Rahiman A; Saver JL; Porter V; Buxton W; McNair N; Razinia T; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2008; 17(1):5-8. PubMed ID: 18190814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensuring management of vascular risk factors after stroke.
    Ovbiagele B; Saver JL
    Rev Neurol Dis; 2006; 3(3):93-100. PubMed ID: 17047574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program.
    LaBresh KA; Reeves MJ; Frankel MR; Albright D; Schwamm LH
    Arch Intern Med; 2008 Feb; 168(4):411-7. PubMed ID: 18299497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical pathways for the management of stroke and intracerebral hemorrhage: a survey of US hospitals.
    Cooper D; Jauch E; Flaherty ML
    Crit Pathw Cardiol; 2007 Mar; 6(1):18-23. PubMed ID: 17667882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program.
    Fonarow GC; Gawlinski A; Watson K
    Crit Pathw Cardiol; 2003 Jun; 2(2):61-70. PubMed ID: 18340322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing vascular risk reduction in the stroke patient with atherothrombotic disease.
    Ovbiagele B
    Med Princ Pract; 2010; 19(1):1-12. PubMed ID: 19996612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pessin award lecture 2008: lessons from the Stroke PROTECT program.
    Ovbiagele B
    J Neurol Sci; 2008 Dec; 275(1-2):1-6. PubMed ID: 18722629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina.
    Christensen MC; Previgliano I; Capparelli FJ; Lerman D; Lee WC; Wainsztein NA
    Acta Neurol Scand; 2009 Apr; 119(4):246-53. PubMed ID: 18771525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after stroke: risk of recurrent ischemic stroke and other events.
    Elkind MS
    Am J Med; 2009 Apr; 122(4 Suppl 2):S7-13. PubMed ID: 19332241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack.
    Schwamm LH; Fonarow GC; Reeves MJ; Pan W; Frankel MR; Smith EE; Ellrodt G; Cannon CP; Liang L; Peterson E; Labresh KA
    Circulation; 2009 Jan; 119(1):107-15. PubMed ID: 19075103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics.
    Bushnell C; Zimmer L; Schwamm L; Goldstein LB; Clapp-Channing N; Harding T; Drew L; Zhao X; Peterson E;
    Am Heart J; 2009 Mar; 157(3):428-435.e2. PubMed ID: 19249411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national survey of acute cerebrovascular disease in Israel: burden, management, outcome and adherence to guidelines.
    Tanne D; Goldbourt U; Koton S; Grossman E; Koren-Morag N; Green MS; Bornstein NM;
    Isr Med Assoc J; 2006 Jan; 8(1):3-7. PubMed ID: 16450742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack.
    Yeh PS; Lin HJ; Bai CH; Hsieh FI; Ke DS; Li YH;
    Am J Cardiol; 2010 May; 105(10):1490-4. PubMed ID: 20451701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
    Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].
    Ma RH; Wang YJ; Wang CX; Zhao XQ; Wang YL; Xu MJ; Wei M; Li Y; Zhang Z; Zhang WW; Wang L; Lin L; Li HT; Zheng T; Wang XW; Li JJ; Lü Y; Qi D
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2618-22. PubMed ID: 19080709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and in-hospital outcomes in stroke and myocardial infarction patients.
    Ivanusa M; Ivanusa Z
    BMC Public Health; 2004 Jul; 4():26. PubMed ID: 15236659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
    Kirshner HS
    J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.